Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany.
Identifieur interne : 000278 ( Main/Exploration ); précédent : 000277; suivant : 000279Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany.
Auteurs : Robert Arnou [France] ; Matthias Frank ; Thomas Hagel ; Alice PrébetSource :
- Advances in therapy [ 1865-8652 ] ; 2011.
Descripteurs français
- KwdFr :
- Acceptation des soins par les patients (MeSH), Allemagne (MeSH), Attitude du personnel soignant (MeSH), France (MeSH), Grippe humaine (prévention et contrôle), Humains (MeSH), Injections intradermiques (instrumentation), Médecins généralistes (psychologie), Sujet âgé (MeSH), Vaccination (instrumentation), Vaccination (méthodes), Vaccination (psychologie), Vaccins antigrippaux (administration et posologie).
- MESH :
- administration et posologie : Vaccins antigrippaux.
- méthodes : Vaccination.
- prévention et contrôle : Grippe humaine.
- psychologie : Médecins généralistes, Vaccination.
- Acceptation des soins par les patients, Allemagne, Attitude du personnel soignant, France, Humains, Injections intradermiques, Sujet âgé, Vaccination.
- Wicri :
English descriptors
- KwdEn :
- Aged (MeSH), Attitude of Health Personnel (MeSH), France (MeSH), General Practitioners (psychology), Germany (MeSH), Humans (MeSH), Influenza Vaccines (administration & dosage), Influenza, Human (prevention & control), Injections, Intradermal (instrumentation), Patient Acceptance of Health Care (MeSH), Vaccination (instrumentation), Vaccination (methods), Vaccination (psychology).
- MESH :
- chemical , administration & dosage : Influenza Vaccines.
- geographic : France, Germany.
- instrumentation : Injections, Intradermal, Vaccination.
- methods : Vaccination.
- prevention & control : Influenza, Human.
- psychology : General Practitioners, Vaccination.
- Aged, Attitude of Health Personnel, Humans, Patient Acceptance of Health Care.
Abstract
INTRODUCTION
The elderly are at high risk of severe seasonal influenza and influenza-related death. Annual vaccination can effectively prevent influenza and its complications, and is recommended in the elderly. In the present study, surveys were undertaken in France and Germany to determine whether INTANZA (sanofi pasteur, Val-de-Reuil, France), the first intradermal influenza vaccine, administered using an innovative microneedle injection system, might influence physicians' likelihood of recommending influenza vaccination or the likelihood that the general public would seek influenza vaccination.
METHODS
Physicians (France: n=260; Germany: n=223) and members of the general public aged ≥ 50 years (France: n=1706; Germany: n=1072) completed online surveys. Details of the INTANZA delivery system, and a "product profile" based on the properties of INTANZA, were presented.
RESULTS
Most physicians and the general public found INTANZA and its microneedle injection system appealing. The main benefit of INTANZA, as perceived by physicians and the public, was the small needle size. Physicians also found the high immunogenicity compared with conventional intramuscular (IM) vaccines attractive. The majority of physicians believed that INTANZA would strongly help them to recommend vaccination to their unvaccinated patients (66% to 91%, depending upon patient characteristics); most (61% to 78%) would prefer to prescribe INTANZA rather than an IM vaccine. More than two-thirds of the unvaccinated general public would prefer INTANZA over IM vaccines, and the option of vaccination with INTANZA would encourage a large proportion of them to get vaccinated (60% to 74%), if it was recommended and they were given the choice. Physicians (≥ 82%) agreed that INTANZA may help increase vaccination coverage rates.
CONCLUSION
The results of these surveys indicate that the availability of INTANZA may encourage physicians to recommend influenza vaccination, and members of the general public to get vaccinated. INTANZA may help to improve seasonal influenza vaccination coverage rates.
DOI: 10.1007/s12325-011-0035-z
PubMed: 21626269
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany.</title><author><name sortKey="Arnou, Robert" sort="Arnou, Robert" uniqKey="Arnou R" first="Robert" last="Arnou">Robert Arnou</name><affiliation wicri:level="3"><nlm:affiliation>ALTI Clinical Research Network, 49000, Angers, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>ALTI Clinical Research Network, 49000, Angers</wicri:regionArea><placeName><region type="region" nuts="2">Pays de la Loire</region><settlement type="city">Angers</settlement></placeName></affiliation></author><author><name sortKey="Frank, Matthias" sort="Frank, Matthias" uniqKey="Frank M" first="Matthias" last="Frank">Matthias Frank</name></author><author><name sortKey="Hagel, Thomas" sort="Hagel, Thomas" uniqKey="Hagel T" first="Thomas" last="Hagel">Thomas Hagel</name></author><author><name sortKey="Prebet, Alice" sort="Prebet, Alice" uniqKey="Prebet A" first="Alice" last="Prébet">Alice Prébet</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21626269</idno><idno type="pmid">21626269</idno><idno type="doi">10.1007/s12325-011-0035-z</idno><idno type="wicri:Area/Main/Corpus">000287</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000287</idno><idno type="wicri:Area/Main/Curation">000287</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000287</idno><idno type="wicri:Area/Main/Exploration">000287</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany.</title><author><name sortKey="Arnou, Robert" sort="Arnou, Robert" uniqKey="Arnou R" first="Robert" last="Arnou">Robert Arnou</name><affiliation wicri:level="3"><nlm:affiliation>ALTI Clinical Research Network, 49000, Angers, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>ALTI Clinical Research Network, 49000, Angers</wicri:regionArea><placeName><region type="region" nuts="2">Pays de la Loire</region><settlement type="city">Angers</settlement></placeName></affiliation></author><author><name sortKey="Frank, Matthias" sort="Frank, Matthias" uniqKey="Frank M" first="Matthias" last="Frank">Matthias Frank</name></author><author><name sortKey="Hagel, Thomas" sort="Hagel, Thomas" uniqKey="Hagel T" first="Thomas" last="Hagel">Thomas Hagel</name></author><author><name sortKey="Prebet, Alice" sort="Prebet, Alice" uniqKey="Prebet A" first="Alice" last="Prébet">Alice Prébet</name></author></analytic><series><title level="j">Advances in therapy</title><idno type="eISSN">1865-8652</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged (MeSH)</term><term>Attitude of Health Personnel (MeSH)</term><term>France (MeSH)</term><term>General Practitioners (psychology)</term><term>Germany (MeSH)</term><term>Humans (MeSH)</term><term>Influenza Vaccines (administration & dosage)</term><term>Influenza, Human (prevention & control)</term><term>Injections, Intradermal (instrumentation)</term><term>Patient Acceptance of Health Care (MeSH)</term><term>Vaccination (instrumentation)</term><term>Vaccination (methods)</term><term>Vaccination (psychology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Acceptation des soins par les patients (MeSH)</term><term>Allemagne (MeSH)</term><term>Attitude du personnel soignant (MeSH)</term><term>France (MeSH)</term><term>Grippe humaine (prévention et contrôle)</term><term>Humains (MeSH)</term><term>Injections intradermiques (instrumentation)</term><term>Médecins généralistes (psychologie)</term><term>Sujet âgé (MeSH)</term><term>Vaccination (instrumentation)</term><term>Vaccination (méthodes)</term><term>Vaccination (psychologie)</term><term>Vaccins antigrippaux (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Influenza Vaccines</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term><term>Germany</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Vaccins antigrippaux</term></keywords><keywords scheme="MESH" qualifier="instrumentation" xml:lang="en"><term>Injections, Intradermal</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="psychologie" xml:lang="fr"><term>Médecins généralistes</term><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>General Practitioners</term><term>Vaccination</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Attitude of Health Personnel</term><term>Humans</term><term>Patient Acceptance of Health Care</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Acceptation des soins par les patients</term><term>Allemagne</term><term>Attitude du personnel soignant</term><term>France</term><term>Humains</term><term>Injections intradermiques</term><term>Sujet âgé</term><term>Vaccination</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term><term>Allemagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>INTRODUCTION</b></p><p>The elderly are at high risk of severe seasonal influenza and influenza-related death. Annual vaccination can effectively prevent influenza and its complications, and is recommended in the elderly. In the present study, surveys were undertaken in France and Germany to determine whether INTANZA (sanofi pasteur, Val-de-Reuil, France), the first intradermal influenza vaccine, administered using an innovative microneedle injection system, might influence physicians' likelihood of recommending influenza vaccination or the likelihood that the general public would seek influenza vaccination.</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>Physicians (France: n=260; Germany: n=223) and members of the general public aged ≥ 50 years (France: n=1706; Germany: n=1072) completed online surveys. Details of the INTANZA delivery system, and a "product profile" based on the properties of INTANZA, were presented.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>Most physicians and the general public found INTANZA and its microneedle injection system appealing. The main benefit of INTANZA, as perceived by physicians and the public, was the small needle size. Physicians also found the high immunogenicity compared with conventional intramuscular (IM) vaccines attractive. The majority of physicians believed that INTANZA would strongly help them to recommend vaccination to their unvaccinated patients (66% to 91%, depending upon patient characteristics); most (61% to 78%) would prefer to prescribe INTANZA rather than an IM vaccine. More than two-thirds of the unvaccinated general public would prefer INTANZA over IM vaccines, and the option of vaccination with INTANZA would encourage a large proportion of them to get vaccinated (60% to 74%), if it was recommended and they were given the choice. Physicians (≥ 82%) agreed that INTANZA may help increase vaccination coverage rates.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>The results of these surveys indicate that the availability of INTANZA may encourage physicians to recommend influenza vaccination, and members of the general public to get vaccinated. INTANZA may help to improve seasonal influenza vaccination coverage rates.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21626269</PMID><DateCompleted><Year>2011</Year><Month>12</Month><Day>07</Day></DateCompleted><DateRevised><Year>2011</Year><Month>07</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1865-8652</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>7</Issue><PubDate><Year>2011</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Advances in therapy</Title><ISOAbbreviation>Adv Ther</ISOAbbreviation></Journal><ArticleTitle>Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany.</ArticleTitle><Pagination><MedlinePgn>555-65</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12325-011-0035-z</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">The elderly are at high risk of severe seasonal influenza and influenza-related death. Annual vaccination can effectively prevent influenza and its complications, and is recommended in the elderly. In the present study, surveys were undertaken in France and Germany to determine whether INTANZA (sanofi pasteur, Val-de-Reuil, France), the first intradermal influenza vaccine, administered using an innovative microneedle injection system, might influence physicians' likelihood of recommending influenza vaccination or the likelihood that the general public would seek influenza vaccination.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Physicians (France: n=260; Germany: n=223) and members of the general public aged ≥ 50 years (France: n=1706; Germany: n=1072) completed online surveys. Details of the INTANZA delivery system, and a "product profile" based on the properties of INTANZA, were presented.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Most physicians and the general public found INTANZA and its microneedle injection system appealing. The main benefit of INTANZA, as perceived by physicians and the public, was the small needle size. Physicians also found the high immunogenicity compared with conventional intramuscular (IM) vaccines attractive. The majority of physicians believed that INTANZA would strongly help them to recommend vaccination to their unvaccinated patients (66% to 91%, depending upon patient characteristics); most (61% to 78%) would prefer to prescribe INTANZA rather than an IM vaccine. More than two-thirds of the unvaccinated general public would prefer INTANZA over IM vaccines, and the option of vaccination with INTANZA would encourage a large proportion of them to get vaccinated (60% to 74%), if it was recommended and they were given the choice. Physicians (≥ 82%) agreed that INTANZA may help increase vaccination coverage rates.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The results of these surveys indicate that the availability of INTANZA may encourage physicians to recommend influenza vaccination, and members of the general public to get vaccinated. INTANZA may help to improve seasonal influenza vaccination coverage rates.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arnou</LastName><ForeName>Robert</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>ALTI Clinical Research Network, 49000, Angers, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frank</LastName><ForeName>Matthias</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hagel</LastName><ForeName>Thomas</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Prébet</LastName><ForeName>Alice</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2011</Year><Month>05</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Adv Ther</MedlineTA><NlmUniqueID>8611864</NlmUniqueID><ISSNLinking>0741-238X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>T</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001291" MajorTopicYN="N">Attitude of Health Personnel</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058005" MajorTopicYN="N">General Practitioners</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007271" MajorTopicYN="N">Injections, Intradermal</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010342" MajorTopicYN="Y">Patient Acceptance of Health Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000295" MajorTopicYN="N">instrumentation</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2011</Year><Month>03</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>6</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>12</Month><Day>13</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21626269</ArticleId><ArticleId IdType="doi">10.1007/s12325-011-0035-z</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>France</li></country><region><li>Pays de la Loire</li></region><settlement><li>Angers</li></settlement></list><tree><noCountry><name sortKey="Frank, Matthias" sort="Frank, Matthias" uniqKey="Frank M" first="Matthias" last="Frank">Matthias Frank</name><name sortKey="Hagel, Thomas" sort="Hagel, Thomas" uniqKey="Hagel T" first="Thomas" last="Hagel">Thomas Hagel</name><name sortKey="Prebet, Alice" sort="Prebet, Alice" uniqKey="Prebet A" first="Alice" last="Prébet">Alice Prébet</name></noCountry><country name="France"><region name="Pays de la Loire"><name sortKey="Arnou, Robert" sort="Arnou, Robert" uniqKey="Arnou R" first="Robert" last="Arnou">Robert Arnou</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/GrippeAllemagneV4/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000278 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000278 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= GrippeAllemagneV4
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:21626269
|texte= Willingness to vaccinate or get vaccinated with an intradermal seasonal influenza vaccine: a survey of general practitioners and the general public in France and Germany.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:21626269" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a GrippeAllemagneV4
| This area was generated with Dilib version V0.6.35. |  |